22q11.2 microdeletions result in specific cognitive deficits and schizophrenia. Analysis of Df(16)A +/À mice, which model this microdeletion, revealed abnormalities in the formation of neuronal dendrites and spines, as well as altered brain microRNAs. Here, we show a drastic reduction of miR-185, which resides within the 22q11.2 locus, to levels more than expected by a hemizygous deletion, and we demonstrate that this reduction alters dendritic and spine development. miR-185 represses, through an evolutionarily conserved target site, a previously unknown inhibitor of these processes that resides in the Golgi apparatus and shows higher prenatal brain expression. Sustained derepression of this inhibitor after birth represents the most robust transcriptional disturbance in the brains of Df (16)A +/À mice and results in structural alterations in the hippocampus. Reduction of miR-185 also has milder age-and region-specific effects on the expression of some Golgi-related genes. Our findings illuminate the contribution of microRNAs in psychiatric disorders and cognitive dysfunction.
INTRODUCTION
The identification of a widespread role of chromosomal microdeletions and microduplications (copy number variants or CNVs) in determining susceptibility to psychiatric disorders such as schizophrenia (SCZ), as well as neurodevelopmental disorders such as autism and intellectual disability, represents a shift in our understanding of the genetic architecture of these disorders and highlights the pervasive contribution of rare and highly penetrant structural mutations (Karayiorgou et al., 1995; Morrow, 2010; Rodriguez-Murillo et al., 2012) . Along these lines, a strong link has been established between microdeletions in chromosome 22q11.2, cognitive dysfunction and psychiatric disorders, especially SCZ (Karayiorgou et al., 1995 Xu et al., 2008) . Understanding how the genes disrupted by this deletion contribute to the ensuing psychiatric and cognitive phenotypes will provide important mechanistic insights and guide analysis of other pathogenic mutations (Arguello and Gogos, 2006 , 2010 International Schizophrenia Consortium, 2008; Karayiorgou et al., 2010) .
By using chromosomal engineering, we generated a mouse model carrying a hemizygous 1.3 Mb chromosomal deficiency on mouse chromosome 16 (Df(16)A), which is syntenic to the 1.5 Mb 22q11.2 microdeletion . Analysis of Df(16)A +/À mice showed abnormalities in dendritic morphogenesis and formation of dendritic spines of hippocampal pyramidal neurons both in culture and in vivo (Mukai et al., 2008; Stark et al., 2008) . Such changes may account, at least in part, for the regional decreases in gray matter volumes observed in some 22q11.2 deletion carriers (Bearden et al., 2009; Chow et al., 2002) and may ultimately lead to altered information processing. Analysis of the Df(16)A +/À strain also provided compelling evidence that the 22q11.2 microdeletion results in abnormal processing of brain microRNAs (miRNAs), a class of small noncoding RNAs that regulate the stability and translation of mRNAs (Fineberg et al., 2009; Kosik, 2006; Schratt, 2009; Xu et al., 2010) , implicating miRNA dysregulation in the pathogenesis of psychiatric disorders and cognitive dysfunction. One gene disrupted by the 22q11.2 microdeletion is DGCR8, a component of the ''microprocessor'' complex that is essential for miRNA production (Tomari and Zamore, 2005) . Dgcr8 haploinsufficiency results in the downregulation of a specific subset of mature miRNAs and contributes to alterations found in Df(16)A +/À mice (Fé nelon et al., 2011; Stark et al., 2008) . miRNA dysregulation likely accounts for a fraction of the transcript misexpression in the brains of Df(16)A +/À mice , but direct targets have not been reported. Here, we highlight an important component of this dysregulation and identify a previously uncharacterized gene with prenatal expression bias as a major miRNA target mediating the effects of the 22q11.2 microdeletion on neuronal maturation and connectivity.
RESULTS

A Drastic Reduction of miR-185 Levels in Df(16)A +/À Mice
Studies in the Df(16)A +/À mouse strain have shown that the 22q11.2 microdeletion results in abnormal processing of a specific subset of brain miRNAs due to the removal of one copy of the Dgcr8 gene causing a decrease in its expression in the adult brain as well as in early development (Figure S1A available online). It is noteworthy that, in addition to Dgcr8, the 22q11.2 microdeletion and the equivalent mouse deficiency remove one copy of a miRNA gene (miR-185) located within the minimal 1.5 Mb 22q11.2 critical region ( Figure 1A ). In situ hybridization assays indicated that miR-185 is expressed in several brain regions such as hippocampus (HPC) and cortex ( Figure 1B) . qRT-PCR analysis showed that expression of miR-185 is dramatically reduced by $70%-80% in both HPC (p < 10 À6 ) and prefrontal cortex (PFC; p < 10 À11 ) of adult Df (16) A +/À mice as compared to wild-type (WT) littermates ( Figures  1C and 1D ). This reduction was also observed at earlier developmental stages (embryonic day 17 [E17] and postnatal day 6 [P6]) ( Figure S1B ). miR-185 also showed a more modest decrease in Dgcr8 +/À mice ($20% in HPC; p < 0.05; Figure 1E ), suggesting that the severe reduction of mature miR-185 expression in Df(16)A +/À mice may be due to a combined effect of hemizygosity of the miR-185 gene and impaired maturation of the pri-mir-185 transcript produced from the remaining copy, due to the reduction in Dgcr8 levels. Such a large reduction in expression of a resident gene to levels greater than expected by the 50% decrease in gene dosage is unique among genes affected by the 22q11.2 microdeletion.
A Primary Transcriptional Consequence of 22q11.2 Genomic Loss
Previous microarray analysis of adult Df(16)A +/À mice revealed genome-wide alterations of transcriptional programs in the HPC and PFC . We extended expression (16)A +/À (n = 7 for mutant, n = 9 for WT) and in HPC (E) of Dgcr8 +/À (n = 10 for mutant and WT), as assayed by qRT-PCR. Expression levels in mutant mice were normalized to their respective WT littermates. Results are expressed as mean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (Student's t test). See also Figure S1 . profile analysis of these two brain regions to two earlier developmental stages, E17 and P6. Only one gene, 2310044H10Rik, was consistently significantly upregulated (in at least two of the three developmental stages examined and in at least one of the two brain areas tested). Indeed, 2310044H10Rik was among the top upregulated genes in both postnatal stages examined (Figures 2A and 2B) . Notably, no significant difference in 2310044H10Rik expression was found in either frontal cortex or HPC at E17 (Figures 2A and 2B) . Importantly, there is no known miRNA within or surrounding this genomic locus, suggesting that the upregulation is not due to impaired processing of overlapping pri-miRNA transcripts.
In independent experiments, we attempted to distinguish primary versus secondary gene targets of the 22q11.2 microdeletion by looking for genes whose expression changes in opposite direction as a result of genomic losses or gains in this locus. Such genes are likely to represent primary targets and direct transcriptional readouts of the underlying copy number imbalances (Chahrour et al., 2008) . We compared the PFC and HPC gene expression profiles in mice carrying a deletion or duplication at the 22q11.2 syntenic mouse locus using as reference compound heterozygous mice balanced for copy number (see Extended Experimental Procedures; Figure S2 ). We identified a number of inversely altered transcripts in either PFC or HPC (p < 0.001; Extended Experimental Procedures; Table  S1 ), in addition to the transcripts from the 22q11.2 region. As expected, the majority of the identified transcripts are primiRNA forms. Only 12 transcripts were significantly misregulated in a reciprocal manner in both PFC and HPC (Table S2) . Among them, 2310044H10Rik is the only gene with proteincoding potential.
Taken together, our expression profiling highlighted the misregulation of 2310044H10Rik as a major consequence of the 22q11.2 genomic imbalances at the transcriptome level. We confirmed the pattern of 2310044H10Rik upregulation in both PFC and HPC by TaqMan qRT-PCR (PFC: E17, 20%, p = 0.24; P6, 59%, p < 0.01; Adult, 76%, p < 10 À6 ; HPC: E17, 20%, p = (Grimson et al., 2007) and mirDB (Wang, 2008) , report that the 3 0 UTR of 2310044H10Rik contains binding sites of miRNAs shown to be affected in Df(16)A +/À mice by microarray profiling . Specifically, mirDB predicted five such miRNAs with binding sites in the 3 0 UTR of 2310044H10Rik including miR-185 and miR-485, whereas TargetScan predicted 13 miRNA sites, including sites for miR-185, miR-485, miR-491, and miR-224. Notably, both programs predicted sites for miR-185 and miR-485 ( Figure 3A , red rectangles).
Because increased brain expression of 2310044H10Rik is recapitulated in Df(16)A +/À primary neurons ( Figure 2E ), we first used primary neurons to determine whether endogenous 2310044H10Rik expression is actually under the control of miR-185. To examine the effect of miR-185 overexpression on 2310044H10Rik level, we introduced into primary neuronal cultures a miRNA precursor mimic (''pre-mir-185''), which is processed into mature miRNA, or a scramble precursor (''prescramble'') with no homology to the mouse genome, which serves as a control for nonspecific effects of small RNA expression. Twenty-four hours posttransfection, there was a decrease in the levels of 2310044H10Rik in pre-mir-185-transfected neurons when compared to prescramble-transfected neurons (p < 0.01; Figure 3B ). In a complementary experiment, introduction of an anti-miR-185 LNA oligo or a scramble control oligo resulted in an increase of 2310044H10Rik mRNA levels in anti-miR-185-transfected cells when compared to scramble-transfected cells (p < 0.05; Figure 3C ). Taken together, these results confirm that 2310044H10Rik expression in primary neurons is under the repressive control of miR-185. Essentially identical results were obtained when 2310044H10Rik expression was assayed in N18 cells ( Figures 3D and 3E ). Therefore, we used this cell line to further characterize the miR-185-mediated inhibition.
To test whether the inhibition of miR-185 on 2310044H10Rik expression is 3 0 UTR dependent as predicted by TargetScan and mirDB (see above), 2310044H10Rik 3 0 UTR-fused luciferase reporter genes were cotransfected with either pre-mir-185 mimic or prescramble into N18 cells. Although prescramble did not affect the reporter activity, introduction of pre-mir-185 mimic led to a dramatic decrease of luciferase activity as compared to the prescramble control (p < 0.001 for all pre-mir-185 concentrations used; Figure 3F ). To investigate whether miR-185-mediated repression is specific and operates directly via the two binding sites predicted by TargetScan ( Figure 3A) , we engineered luciferase reporters carrying mutated versions of 2310044H10Rik 3 0 UTR with either individual or both miR-185 binding sites mutated (Mut1:Site 1 mutant; Mut2:Site 2 mutant; Mut1&2:Site 1 and 2 mutants, see Extended Experimental Procedures). The pre-mir-185 mimic significantly reduced the luciferase activity of the WT reporter to $25% relative to a control reporter without 3 0 UTR, whereas it reduced the luciferase activities of the Mut1 and Mut2 reporters to 80% (p < 0.01) and 33% Results are expressed as mean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (Student's t test). See also Figure S2 and Tables S1 and S2. (p < 0.05), respectively ( Figure 3G ). Notably, the pre-mir-185 mimic could not repress luciferase activity driven from a mutant reporter where both binding sites are simultaneously disrupted ( Figure 3G ). Thus, both miR-185 cognate binding sites have an impact on the 3 0 UTR-mediated regulation of 2310044H10Rik expression, although the site disrupted in the Mut1 reporter (Site 1) seems to be the major target site via which miR-185 directly exerts its repressive effect.
We further addressed the dependence of 2310044H10Rik 3 0 UTR reporter repression on the levels of miR-485 or miR-491, which are also predicted to target binding sites in the 3 0 UTR of the 2310044H10Rik gene. Both of these miRNAs are modestly downregulated in the HPC of the Df(16)A +/À mice due to Dgcr8 hemizygosity ( Figure S3B ). The pre-miRNA mimics of either miRNA modestly but significantly reduced the luciferase activity of the 3 0 UTR-fused reporter compared to the prescramble control (pre-mir-485: 27%, p < 0.05; pre-mir-491: 35%, p < 0.05; Figure 3H ). A three-factor ANOVA indicated that all three miRNAs (miR-185, miR-485, and miR-491) and their interactions have significant impact on the luciferase activity with the exception of the interaction between miR-485 and miR-491 (Table S3 ). Results are expressed as mean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (Student's t test). See also Figure S3 and Table S3 .
Taken together, these findings suggest that the persistent elevation of 2310044H10Rik levels observed in Df(16)A +/À mice is likely the result of the combined hemizygosity at miR-185 and Dgcr8 loci. Although more than one miRNA contributes, the major effect is due to the dramatic downregulation of miR-185. Consistent with this notion and the less profound reduction of miR-185 in Dgcr8 +/À mice ( Figure 1E ), 2310044H10Rik is only modestly upregulated in this strain ( Figure S3A ). Interestingly, a comparison between the 3 0 UTR of human and mouse orthologs ( Figure 3A ) reveals that miR-185 cognate Site 1 as well as one miR-485 binding site are located within a highly conserved region, suggesting that these sites are critical in regulating the levels of the human ortholog (C19orf63). Consistent with this expectation, introduction of pre-mir-185 into human 293T cells resulted in a significant decrease of endogenous C19orf63 levels ( Figure S3C ). In addition, similar to the pattern observed in the mouse brain, expression of C19orf63 decreases in infant brain as depicted in BrainSpan database (http://www.brainspan.org).
It is noteworthy that inspection of our gene expression data set as well as qRT-PCR analysis of a sample of eight high-likelihood miR-185 targets identified by more than one prediction program did not reveal any additional significant changes of transcript levels in the brains of Df (16)A +/À mice ( Figure S3D ).
Furthermore, unlike 2310044H10Rik, none of the other top upregulated protein-coding genes (shown in Figure 2B ) are consistently altered in both HPC and frontal cortex of E17, P6, and adult Df(16)A +/À mice, and only one of them (B3gat1, see below) is predicted to contain miR-185 seed sites in its 3 0 UTR. Overall, although additional downstream targets of miR-185 likely exist (see below), our analysis suggests that 2310044H10Rik represents the major downstream effector of miR-185 and a major hub target of miRNA dysregulation due to the 22q11.2 microdeletion. Due to confirmed miRNA-mediated regulation, we renamed the gene Mirta22 (miRNA target of the 22q11.2 microdeletion).
Mirta22 Encodes a Neuronal Protein Residing in the Golgi Apparatus
Mirta22 encodes a 28 kDa protein without any known sequence homology or functional domain (http://www.uniprot.org/uniprot/ Q3TAS6). The murine ortholog is located on mouse chromosome 7 and contains seven coding exons. The human ortholog (C19orf63) is located on chromosome 19q13.33 and encodes a protein with 92.3% identity to the murine protein ( Figure 4A ). One mouse reference sequence (isoform 1) is reported in GenBank, whereas two C19orf63 isoforms (isoform 1 and 2) are reported in GenBank and in the literature (Junes-Gill et al., 2011) . The protein encoded by isoform 1 is predicted to contain a N-terminal signal peptide, as well as a transmembrane segment ( Figure 4A , red rectangles), which separates a long N-terminal region from a short C-terminal segment that contains a polyglycine tail with unknown function. Isoform 2 differs from isoform 1 by an alternatively spliced exon located after exon 6. The protein encoded by isoform 2 is shorter by eight amino acids, contains the N-terminal signal peptide but not the transmembrane segment, and is predicted to be secreted ( Figure 4A ). We raised a polyclonal antibody against a segment of the protein that is conserved in the mouse and human orthologs (amino acids 207-226, Figure 4A , green rectangle; see Extended Experimental Procedures; Figure S4 ). We validated the specificity of the antibody using a number of assays (see Extended Experimental Procedures; Figures S4A-S4C ) and showed that it can also detect the secreted form of the protein in 293T cell cultures ( Figure S4D ). Western blot assays of protein extracts from the brain of Df (16) Figure 4C ).
Immunostaining of neuronal cultures showed that Mirta22 is primarily a neuronal protein ( Figure 4D, top) . At the subcellular level, it is found primarily in the soma, where it colocalizes with the Golgi apparatus marker GM130 (Nakamura et al., 1995) . As the neurons mature, it is also found in vesicles and tubular-like clusters within the dendritic shafts ( Figure 4D , middle). Mirta22 immunoreactivity was not detected in cultures stained with preimmune serum ( Figure S4E ) and was diminished by 64% in Mirta22 shRNA-transfected neurons (Figures S4F and S4G, lower panel) . Immunohistochemical analysis demonstrated that Mirta22 is widely distributed in the brain, where it is localized in neurons ( Figure 4D , bottom).
miR-185 Reduction Results in Coordinated Mild
Dysregulation of Golgi-Related Genes Accumulating evidence suggests that miRNAs may target functionally connected genes, often in a developmental stagespecific manner (Tsang et al., 2010; Zhang et al., 2009) mice showed a significant enrichment in the adult HPC expression profile (p = 5 3 10 À4 ) where, as expected, most of the top genes were upregulated (n = 34), and only four genes were downregulated (p < 0.005, Figure 5B ; Table S4 ). A considerably more modest enrichment was suggested for the E17 (p = 0.02) and P6 HPC (p = 0.016) profiles ( Figure S5 ). Interestingly, there was no significant enrichment within the PFC profiles in any of the three ages tested (E17: p = 0.6311; P6: p = 0.1326; adult: p = 0.244). Expression changes were modest, with only 4 of 159 Golgirelated probe sets included among the top 100 in the adult HPC. (A) Top view shows the structure of mRNA transcripts of 2310044H10Rik (Mirta22) and its human ortholog, C19orf63. RefSeq reports a 2310044H10Rik (Mirta22) transcript with seven exons (blue rectangles), which is predicted to encode a signal peptide and a transmembrane domain (red rectangles ; n = 34 for WT). Expression levels in mutant neurons were normalized to WT neurons. Results are expressed as mean ±SEM. *p < 0.05 (Student's t test).
(D) Upper panel shows that 2310044H10Rik (Mirta22) colocalizes with neuron-specific marker NeuN, but not with glia-specific marker GFAP, in cultured hippocampal neurons at DIV20. Middle panel shows that 2310044H10Rik (Mirta22) (green) colocalizes with Golgi-specific marker GM130 (red) in the soma. 2310044H10Rik (Mirta22) is also found in vesicles and tubular-like clusters in the dendrites, which are highlighted by the dendritic marker MAP2 (blue). Lower panel presents distribution of 2310044H10Rik (Mirta22) protein in adult mouse brain. Sections were stained with 2310044H10Rik (Mirta22) antibody. Images were taken at 43, 103, 203, and 403 magnifications as indicated. Red boxes in 43, 103, and 203 images outline the area shown in 103, 203, and 403 images, respectively. See also Figure S4 . et al., 2008) . We introduced an anti-miR-185 and a scramble control LNA oligo into WT primary hippocampal neurons and measured dendritic and spine morphology 2 days posttransfection at DIV9 and DIV19, respectively. Analysis of dendritic architecture indicated that reduction of miR-185 levels leads to deficits in dendritic complexity ( Figure 6A ), including a significant reduction in the number of primary dendrites (21%, p < 0.05; Figure 6B ) and a significant reduction in total branchpoints in transfected neurons (16%, p < 0.05; Figure 6C ). This finding was confirmed by Sholl analysis, which compares branchpoint numbers at varying distances from the soma ( Figure S6D ). Moreover, reduction of miR-185 levels in DIV19 neurons results in decreased spine density (21%, p < 0.05; Figures 6D, 6E , and S6E) and a significant reduction in their median width (15% decrease, p < 0.001, Kolmogorov-Smirnov test; Figure 6F ). Consistently, introduction of pre-mir-185 mimic into WT neurons increased the number of primary dendrites, number of branchpoints, density, and head width of mushroom spines ( Figures  S6F and S6G) .
We also examined whether elevation of miR-185 levels could, at least partially, reverse cytoarchitectural alterations observed in Df(16)A +/À neurons (Mukai et al., 2008 Figure 6H ) and number of dendritic branchpoints (38%, p < 10 À4 ; Figure 6I ). They also showed reduced spine density (38%, p < 10 À6 ; Figure 6K ) as well as a small but Table S4 ); Rank, the ranking position in the list of all differentially expressed genes according to significance level. Note that the majority (89%, 34 out of 38) of the genes are upregulated. See also Figure S5 and Table S4 . statistically significant decrease in median head width (8% decrease, p < 0.01; Figure 6L ) of mushroom spines. Increase in miR-185 activity largely reversed the deficits in dendritic complexity ( Figures 6H, 6I , and S6H) and the reduction in spine density ( Figures 6K and S6I ) and increased the head width of mushroom spines in Df (16) (Mukai et al., 2008) . We introduced a Mirta22 cDNA into WT primary hippocampal neurons and measured dendritic and spine morphology 2 days posttransfection, at DIV9 and DIV19, respectively. Control experiments using qRT-PCR and western blot confirmed that the Mirta22-encoding plasmid drives increased expression of Mirta22 at both mRNA and protein levels ( Figures S7A and S7B) . Analysis of dendritic architecture indicated that elevation of Mirta22 levels results in a significant reduction in the number of primary dendrites (18%, p < 0.001; Figure S7C ) and total branchpoints in transfected neurons (41%, p < 10
À5
; Figure S7D ). This finding was confirmed by Sholl analysis ( Figure S7E ). Moreover, elevation of Mirta22 levels in DIV19 neurons results in decreased spine density (22%, p < 0.05; Figure S7F ) and a small but significant reduction in the mushroom spine median width (8% decrease, p < 0.001, Kolmogorov-Smirnov test; Figure S7G ). These structural deficits recapitulate those observed in Df(16)A +/À neurons, suggesting that these deficits are, at least in part, due to the aberrantly high levels of Mirta22.
We also asked whether reduction of Mirta22 levels could, at least partially, reverse cytoarchitectural alterations observed in Df(16)A +/À neurons (Mukai et al., 2008) . We transfected primary hippocampal neurons isolated from Df(16)A +/À embryos and their WT littermates with constructs that coexpress turbo RFP (tRFP) and either a shRNA engineered to knock down expression of endogenous mouse Mirta22 or a scramble control shRNA (scr shRNA). We confirmed that the Mirta22 shRNA can effectively knock down the expression of Mirta22 at both mRNA and protein levels ( Figures S7H and S7I ). We analyzed dendritic architecture and spine morphology 2 days following transfection, at DIV9 and DIV19, respectively. Introduction of Mirta22 shRNA restored to WT levels the number of primary dendrites of Df (16)A +/À neurons at DIV9 (Mirta22 shRNA versus scr shRNA, 40% increase, p < 10
; Figure 7A ). A trend for increase in the total number of branchpoints in Df(16)A +/À neurons was also observed (25% increase, p = 0.16; Figure S7J ). Sholl analysis confirmed that introduction of Mirta22 shRNA in Df(16)A +/À neurons increased branchpoint numbers mainly in the proximal dendritic segments from the soma ( Figure S7K ). Furthermore, whereas DIV19 Df(16)A +/À neurons transfected with the control shRNA had fewer and thinner mushroom spines than WT neurons, introduction of Mirta22 shRNA into Df(16)A +/À neurons reversed the deficit in density (Mirta22 shRNA versus scr shRNA, 91% increase, p < 10 À6 ; Figure 7B ), whereas it had no significant impact on spine width ( Figure 7C ). The observation that reduction of Mirta22 levels partially reverses the structural deficits observed in Df(16)A +/À mice was confirmed by using an independent Mirta22 shRNA ( Figures S7L-S7N ) and strongly suggests that Mirta22 acts as an inhibitor mediating the effects of the structural mutation of dendritic and spine growth.
Reduction of Mirta22 Levels Reverses Structural
Alterations in the HPC of Df (16)A +/À Mice To determine whether Mirta22 plays a role in vivo, we asked whether reduction of Mirta22 levels reverses previously reported deficits in dendritic and spine formation at hippocampal CA1 pyramidal neurons of Df (16)A +/À mice (Mukai et al., 2008) . To this end, we used Mirta22 mutant mice (2310044H10Rik Gt(OST181617)Lex /Mmucd) carrying a retroviral gene trap insertion into intron 1 ( Figure 7D ). We confirmed that the insertion results in drastic reduction of Mirta22 transcript and protein levels in the HPC of mutant mice ( Figures 7E and  7F ). We then crossed this line with Df(16)A +/À mice to generate mice compound heterozygous for the Df(16)A and Mirta22 mutations (Df(16)A +/À ;Mirta22 +/À ). Double mutants were compared to single mutants, as well as WT littermates, to evaluate the contribution of Mirta22 upregulation to the dendritic and spine phenotypes induced by Df(16)A. We used diolistics to sparsely label individual HPC neurons with DiI and analyzed dendritic and spine morphology in the CA1 subfield of all four genotypes using confocal imaging. Our analysis confirms previously reported alterations in complexity and spine formation at the basal dendritic tree of CA1 pyramidal neurons of Df (16) ;Mirta22 +/À mice reverses to WT levels the number of primary dendrites and total number of branchpoints ( Figures 7G-7I ). Sholl analysis confirmed that reduction of Mirta22 levels in Df(16)A +/À mice results in increased dendritic branchpoint numbers ( Figure 7J ). Importantly, Mirta22 +/À mice did not differ significantly from WT littermates in any of the tested parameters. Similarly, the presence of the Mirta22 mutation in compound heterozygous Df(16)A +/À ;Mirta22 +/À mice reversed to almost WT levels the Df(16)A-induced deficit in density and size of spines at the basal dendrites of CA1 neurons ( Figures  7K-7M) . Mirta22 +/À mutants did not differ significantly from WT littermates in these two parameters. (legend continued on next page)
DISCUSSION
Accumulating evidence suggests that miRNAs play an important role in the pathogenesis and pathophysiology of psychiatric disorders and cognitive dysfunction (Moreau et al., 2011; Stark et al., 2008; Xu et al., 2010) . Here, we provide a comprehensive view of the pattern of miRNA dysregulation emerging due to 22q11.2 deletions, which is shaped by the combined effect of miR-185 and Dgcr8 hemizygosity. In this context, our results show a considerably greater reduction than the expected 50% decrease in the expression of a 22q11.2 gene, indicating that mechanisms other than simple haploinsufficiency could represent an important and previously unappreciated component of CNV pathogenicity. Along these lines, our results also raise the intriguing possibility that 22q11.2 microdeletions, by partially disabling the miRNA machinery, create a sensitized genetic background, which promotes the effects of deleterious mutations that affect the expression or activity of a subset of miRNAs (Ambros, 2010; Brenner et al., 2010) . By comparing gene expression profiles over three developmental stages and three levels of genomic dosage at the 22q11.2 locus, we identified elevated levels of a previously uncharacterized gene, Mirta22, as the most robust change in gene expression resulting from the 22q11.2 microdeletion, as well as the major downstream transcriptional effect of the 22q11.2-associated miRNA dysregulation. Localization of Mirta22 in the Golgi apparatus and in vesicle and tubular-like extensions in dendrites is consistent with a role in membrane and protein trafficking and secretion, which is necessary for establishment and maintenance of neuronal connections (Evans et al., 2011; Horton et al., 2005; McAllister, 2000; Rosso et al., 2005; Wayman et al., 2006) . Mirta22 is likely to act in concert with other genes within the 22q11.2 deletion , including the Zdhhc8 palmitoyl-transferase, which is also located in the Golgi apparatus and modulates dendritic and spine development (Mukai et al., 2008) . Moreover, although Mirta22 represents a major downstream effector of miR-185 dysregulation, our finding of a coordinated miR-185 targeting of Golgi-apparatus-related genes suggests that Mirta22 upregulation may act, in an age-and brain region-specific manner, in concert with other modestly altered miR-185 targets to interfere with the Golgi-related processes required for neuronal maturation. Thus, our findings highlight a link between the Golgi apparatus and neuronal phenotypes associated with the 22q11.2 microdeletion.
Mirta22 bias toward prenatal expression suggests that this gene may play an important role in both restricting neural circuit formation prenatally, when embryonically generated neurons are still migrating and extending their axons, and in permitting neuronal maturation and synaptogenesis to unfold in the postnatal brain, after neurons have migrated to their final destinations. Consistent with the notion that miRNAs function predominantly as fine-tuning regulators of the expression levels of their targets (Baek et al., 2008; Selbach et al., 2008) , miR-185 and to a lesser extent other miRNAs affected by the 22q11.2 deletion appear to restrict and optimize Mirta22 expression, presumably to avoid excessive inhibition during the critical stage of postnatal synapse formation. Accordingly, sustained derepression of the gene due to genomic loss at the 22q11.2 locus may have an impact on the formation of neural circuits in early postnatal development, as well as on their maintenance during adulthood. Such structural changes could result in local and long-distance disruptions of neuronal communication (Fé nelon et al., 2011; Sigurdsson et al., 2010) , contributing to the cognitive dysfunction, psychiatric phenotypes, or both. In agreement with this prediction, expression of the human ortholog of Mirta22 (C19orf63) declines in infant brains (Kang et al., 2011) .
It has been shown that, during the transition between human fetal and infant development, a large number of genes reverse their direction of expression from an increase in the first two trimesters in utero to a decrease in the third trimester (which corresponds to postnatal development in rodents; Clancy et al., 2007) as well as after birth. Approximately 40% of them are predicted miRNA targets (Colantuoni et al., 2011; Results are expressed as mean ±SEM. *p < 0.05, **p < 0.01, ***p < 0.001 (Student's t test). See also Figure S7 . 2012). In that respect, Mirta22 is one example of a diseaserelated gene representative of this type of transcriptional trajectory indicative of a miRNA-imposed temporal control over the sequential maturation of neurons, synapses, and circuits. Analysis of common variation in the vicinity of the human ortholog (Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium, 2011) identified one SNP (rs10401266) 35 kb upstream of C19orf63 in a presumptive regulatory region with nominally significant association with SCZ (p = 5 3 10 À3 ).
The impact of rare variants in C19orf63 remains to be determined, but importantly, we recently provided evidence that rare de novo deleterious mutations in genes showing a prenatal expression bias and miRNA regulation similar to Mirta22 are enriched in individuals with SCZ, especially those with prominent early prepsychotic, deviant behaviors (Gilman et al., 2012; Xu et al., 2012) . Overall, understanding how Mirta22 affects neuronal connectivity and eventually behavior and cognition is likely to provide more general insights into the contribution of miRNAs in psychiatric and neurodevelopmental disorders, illuminate the patterns of neural complexity underlying these disorders, and facilitate development of new treatments.
EXPERIMENTAL PROCEDURES Mutant Mice
All animal protocols used in this study are approved by Columbia University IACUC. Df(16)A +/À and Dgcr8 +/À mice have been described previously Mukai et al., 2008) and have been backcrossed into C57BL/6J background for over ten generations. Mirta22 mutant mice (2310044H10Rik Gt(OST181617)Lex/ Mmucd, referred to as Mirta22 +/À ) were obtained from the Mutant Mouse Regional Resource Centers supported by NIH.
qRT-PCR and Expression Profiling
Total RNA was isolated by miRNeasy mini kit. qRT-PCR was performed as described previously . For expression profiling, cDNA was generated and exposed to the Affymetrix Mouse genome 430 2.0 array, which includes 45,000 probe sets from >34,000 well-characterized mouse genes. Data were obtained using GeneChip Analysis Software Microarray Suite version 5 and analyzed with limma package in the Bioconductor project (http://www.bioconductor.org). Details are provided in Extended Experimental Procedures.
Analysis of Dendritic Complexity and Spine Morphology
Dissected E17 hippocampal neurons were plated at 2 3 10 5 cells/ml in 6-well plates, cultured for 9-19 days, and transfected with GFP or RFP plasmids depending on the experiment. CA1 pyramidal neurons were sparsely labeled using diolistic labeling (see Extended Experimental Procedures). Images of dendrites and dendritic spines were acquired as described previously by Mukai et al. (2008) . An experimenter blind to the genotype performed imaging and analysis. Details are provided in Extended Experimental Procedures.
Luciferase Assays
Mirta22 3 0 UTR was cloned into psiCHECK2. Binding site mutant clones were generated by PCR-based mutagenesis. N18 neuroblastoma cells were transfected with various psiCHECK2 reporter constructs together with pre-mir-185 mimic or prescramble control unless mentioned otherwise, and luciferase assays were performed using the Promega Dual-Luciferase Reporter Assay System. All experiments were performed at least two times, and all data presented are the average of three technical repeats. Details are provided in Extended Experimental Procedures.
Functional Enrichment Analysis of Predicted miR-185
Targets miR-185 target gene list was imported into DAVID gene functional annotation database. Functional annotation was conducted using the program's functional annotation clustering analysis with default settings. GSEA was conducted using GSEA v.2.0. Details are provided in Extended Experimental Procedures.
Antibodies
A 20 amino acid peptide ([C]-CEQAQKAKNPQEQKSFFAKY-[N]) was used to generate a rabbit polyclonal antibody. Western blot, immunohistochemistry, and immunocytochemistry assays were conducted as previously described (Mukai et al., 2008; Stark et al., 2008) . Details are provided in Extended Experimental Procedures.
ACCESSION NUMBERS
Expression profiling data are available at Gene Expression Omnibus under accession number GSE29767.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven figures, and four tables and can be found with this article online at http://dx.doi. org/10.1016/j.cell.2012.11.052.
